Activation of KRas-ERK1/2 signaling drives the initiation and progression of glioma by suppressing the acetylation of histone H4 at lysine 16
- Type
- Retraction
- Notice date
- 6/18/2020 0:00
- Journal
- Life Sciences
- Publisher
- Elsevier
- Notice DOI
- 10.1016/j.lfs.2020.117903
- Original paper DOI
- 10.1016/j.lfs.2019.03.079
Reasons
- Concerns/Issues about Data
- Concerns/Issues about Image
- Duplication of/in Image
- Objections by Third Party
- Original Data and/or Images not Provided and/or not Available
- Unreliable Results and/or Conclusions